Davis Matthew W.
SEC insider (Form 3/4/5 filer). CIK 0002094283. Chief Development Officer at Aquestive Therapeutics, Inc. (AQST). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 9, 2026. Located in WARREN, NJ.
Companies Davis Matthew W. has filed insider reports for
- Aquestive Therapeutics, Inc. (AQST): Officer, Chief Development Officer
Davis Matthew W.
CIK: 0002094283
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AQST
Aquestive Therapeutics, Inc.
Officer